Vitrolife AB (publ) (VTRLY)
USD 19.8
(0.0%)
USD 19.8
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 757 Million | 636 Million | 384.3 Million | 356.44 Million | 413.33 Million | 349.43 Million |
| Net Income | -3.85 Billion | 537 Million | 459.96 Million | 366.19 Million | 492.69 Million | 398.58 Million |
| Depreciation & Amortization | 425 Million | 396 Million | 108.91 Million | 84.07 Million | 99.38 Million | 84.69 Million |
| Deferred income taxes | -986 Million | -139 Million | -181.07 Million | -95.9 Million | - | - |
| Stock-based compensation | 17 Million | 10 Million | 5 Million | 1.47 Million | - | - |
| Change in working capital | -119 Million | -175 Million | -10.21 Million | 9.84 Million | -61.62 Million | -34.74 Million |
| Other non-cash items | 5.27 Billion | 7 Million | 1.95 Million | -9.23 Million | -117.12 Million | -99.09 Million |
| Investing Cash Flow | -124 Million | -144 Million | -6.51 Billion | -20.21 Million | -112.57 Million | -181.26 Million |
| Investments in PPE | -120 Million | -87 Million | -62.44 Million | -20.08 Million | -87.1 Million | -180.1 Million |
| Acquisitions | -4 Million | -42 Million | -6.46 Billion | 243 Thousand | -23.82 Million | 503 Thousand |
| Investment purchases | - | - | -382 Thousand | -374 Thousand | -1.98 Million | -1.66 Million |
| Sales/Maturities of investments | - | - | 16.23 Million | 13.07 Million | 68 Million | - |
| Other Investing Activities | -1 Million | -15 Million | -5.71 Million | -13.07 Million | -67.66 Million | 503 Thousand |
| Financing Cash Flow | -300 Million | -582 Million | 5.74 Billion | -26.61 Million | -106.89 Million | -81.46 Million |
| Debt repayment | -154 Million | -448 Million | -1.88 Million | -15.76 Million | -14.62 Million | -511 Thousand |
| Dividends payments | -115 Million | -109 Million | -86.79 Million | - | -92.26 Million | -80.95 Million |
| Common Stock Repurchased | - | - | -22.83 Million | - | - | - |
| Common Stock Issuance | - | - | 3.55 Billion | - | - | - |
| Other Financing Activities | -31 Million | -24 Million | 2.3 Billion | -10.84 Million | - | -1000.00 |
| Accounts receivables | -95 Million | -56 Million | -5.54 Million | 14.86 Million | -48.53 Million | -33.99 Million |
| Accounts payables | -9 Million | -48 Million | 42.22 Million | -579 Thousand | 31.21 Million | 3.71 Million |
| Inventory | -15 Million | -71 Million | -46.89 Million | -4.43 Million | -44.3 Million | -4.46 Million |
| Other working capital | -9 Million | - | - | -579 Thousand | 31.21 Million | -30.27 Million |
| Cash at beginning of period | 578 Million | 630 Million | 973.56 Million | 689.53 Million | 490.81 Million | 395.96 Million |
| Cash at end of period | 861 Million | 578 Million | 630.09 Million | 973.56 Million | 689.53 Million | 490.81 Million |
| Capital Expenditure | -120 Million | -87 Million | -62.44 Million | -20.08 Million | -87.1 Million | -180.1 Million |
| Effect of forex changes on cash | -50 Million | 39 Million | 42.01 Million | -25.59 Million | 4.85 Million | 8.13 Million |
| Net cash flow / Change in cash | 283 Million | -52 Million | -343.47 Million | 284.02 Million | 198.72 Million | 94.84 Million |
| Free Cash Flow | 637 Million | 549 Million | 321.85 Million | 336.36 Million | 326.23 Million | 169.32 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 155 Million | 143 Million | 115 Million | -4.17 Billion | -3.85 Billion | 152 Million |
| Depreciation & Amortization | - | 109 Million | 105 Million | 109 Million | 425 Million | 109 Million |
| Deferred income taxes | - | - | - | -17 Million | -986 Million | - |
| Stock-based compensation | - | - | - | 17 Million | 17 Million | - |
| Change in working capital | -35 Million | -23 Million | -39 Million | -1 Million | -119 Million | -17 Million |
| Other non-cash items | 86 Million | 248 Million | 266 Million | 4.22 Billion | 5.27 Billion | -30 Million |
| Investing Cash Flow | -46 Million | -218 Million | -38 Million | -33 Million | -124 Million | -35 Million |
| Investments in PPE | - | -39 Million | -38 Million | -40 Million | -120 Million | -32 Million |
| Acquisitions | - | -178 Million | - | 6 Million | -4 Million | -3 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -46 Million | -40 Million | - | 1 Million | -1 Million | -32 Million |
| Financing Cash Flow | -71 Million | -102 Million | -100 Million | 2 Million | -300 Million | -67 Million |
| Debt repayment | -57 Million | -43 Million | -91 Million | -9 Million | -154 Million | -60 Million |
| Dividends payments | - | -135 Million | - | - | -115 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -14 Million | -10 Million | - | 11 Million | -31 Million | -7 Million |
| Accounts receivables | -21 Million | -81 Million | -62 Million | -49 Million | -95 Million | 57 Million |
| Accounts payables | - | 41 Million | -7 Million | 21 Million | -9 Million | -65 Million |
| Inventory | -34 Million | 17 Million | 30 Million | 27 Million | -15 Million | -8 Million |
| Other working capital | 20 Million | 41 Million | - | - | - | -1 Million |
| Cash at beginning of period | 853 Million | 947 Million | 861 Million | 778 Million | 578 Million | 687 Million |
| Cash at end of period | 925 Million | 853 Million | 947 Million | 861 Million | 861 Million | 778 Million |
| Capital Expenditure | - | -39 Million | -38 Million | -40 Million | -120 Million | -32 Million |
| Effect of forex changes on cash | -17 Million | -10 Million | 26 Million | -57 Million | -50 Million | -21 Million |
| Net cash flow / Change in cash | 72 Million | -94 Million | 86 Million | 83 Million | 283 Million | 91 Million |
| Free Cash Flow | 206 Million | 197 Million | 160 Million | 131 Million | 637 Million | 182 Million |
COM
SMTGY
MAN
RO
RFT
HSN